Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · Environmental Health (93.113)
Опубликован 1 окт. 2024 г. · Осталось примерно 10 месяцев
Простыми словами
Краткое описание на русском пока недоступно; показано на английском.
The US National Institutes of Health funds biologic-based drug discovery and development for nervous system disorders through the Blueprint Neurotherapeutics Network, supporting research from lead optimization through phase I clinical testing with access to NIH-funded consultants and contract research organizations. Eligible applicants include nonprofits, universities, government agencies, small businesses, and foreign organizations, with applications due by 18 August 2027.
Автоматическое краткое изложение текста донора; оригинальная формулировка приведена ниже.
Краткое описание
Исходный текст донора (английский)
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and thereby control the patent prosecution and licensing negotiations) for biotherapeutic candidates developed in this program.
Фрагмент со страницы донора. Полный текст, приложения и формы — в исходном объявлении о конкурсе.
Кто может подать заявку
- НКО / гражданское общество
- Государственный орган
- Академическое или исследовательское учреждение
- Частная компания
Требования и условия
Показать требования из источника · Исходный текст донора (английский)
Applicant types: Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Public and State controlled institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); City or township governments; Special district governments; Public housing authorities/Indian housing authorities; Small businesses; County governments; Independent school districts; State governments; For profit organizations other than small businesses; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal governments (Federally recognized); Private institutions of higher education
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.